GC Cell appointed Kim Jae-wang as the new co-representative, it announced on the 3rd. This comes just a month after former representative James Park was appointed as the new representative of Lotte Biologics following his resignation in November of last year.
Kim Jae-wang, the designated representative, is expected to be formally appointed after the upcoming shareholders' meeting and board of directors meeting, and will lead the company alongside former research institute head Won Seong-yong, who was appointed as the new representative following Park's resignation. With the transition from a sole representative system to a co-representative system, the designated Kim Jae-wang will be in charge of the sales institutional sector, while representative Won Seong-yong will oversee the research and development institutional sector.
The new designated representative Kim graduated from Daegu University with a degree in economics and obtained a master's degree in business administration from Chung-Ang University. He then joined GC Biotechnology through a public recruitment process and has served as the head of the GC Wellbeing IP division after working at GC Cell and GC Biopharma. He has played a key role across various business sectors based on over 34 years of sales experience.
A representative from GC Cell noted that, "With the recruitment of the new designated representative Kim, we plan to establish an organizational structure to secure sustainable growth drivers and accelerate business expansion. By appointing co-representatives for the sales and research and development institutional sectors, we will concentrate our capabilities in each field and strengthen our capabilities as a specialized cell and gene therapy company through complementary leadership."
Currently, the only product commercialized by GC Cell is the immune cell therapy Immuncell-LC. It is a customized anticancer drug made from the patient's own blood, used as a treatment after liver cancer surgery. It is the only approved autologous immune cell therapy in the world for this purpose. GC Cell is also involved in contract development and manufacturing (CDMO), specimen testing services, umbilical cord blood banking, and biopharmaceutical logistics.